2025-03-28 18:53:11
Latest Post
Maithan A1loys Limited purchases 1.99 lakh shares of NSE
Lancor Holdings Ltd updates on new projects
Scheme of amalgamation of Cohance Lifesciences into and with Suven Pharmaceuticals has been sanctioned by NCLT
AstraZeneca Pharma India Ltd to discontinue the manufacturing and marketing of Imdur from April 1, 2025
Aerolloy Technologies secures major order from Safran Aircraft Engines for LEAP Engine Cast Components
Stock Report
Chemcrux Enterprises Ltd reports Rs. 2.21 crore net profit in Q4 FY24
Posted On : 2024-05-06 19:52:01( TIMEZONE : IST )
Chemcrux Enterprises Ltd has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 18.8839 crores during the period ended March 31, 2024 as compared to Rs. 22.3706 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 2.2124 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 2.6614 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 1.49 for the period ended March 31, 2024 as compared to Rs. 1.80 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 18.8839 crs | ₹22.3706 crs |  -15.59% |
| Net Profit | ₹2.2124 crs | ₹2.6614 crs | -16.87% |
| EPS | ₹1.49 | ₹1.80 | -17.22% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 18.8839 crores during the period ended March 31, 2024 as compared to Rs.20.1829 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.2.2124 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.2.9236 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.1.49 for the period ended March 31, 2024 as compared to Rs.1.97 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 18.8839 crs | ₹20.1829 crs | -6.44% |
| Net Profit | ₹2.2124 crs | ₹2.9236 crs | -24.33% |
| EPS | ₹1.49 | ₹1.97 | -24.37% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.79.8007 crores during the Financial Year ended March 31, 2024 as compared to Rs.96.2046 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.8.4443 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.14.3583 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.5.70 for the Financial Year ended March 31, 2024 as compared to Rs.9.70 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹79.8007 crs | ₹96.2046 crs | -17.05% |
| Net Profit | ₹8.4443 crs | ₹14.3583 crs | -41.19% |
| EPS | ₹5.70 | ₹9.70 | -41.24% |
Shares of Chemcrux Enterprises Ltd was last trading in BSE at Rs. 261.65 as compared to the previous close of Rs. 266.85. The total number of shares traded during the day was 13670 in over 863 trades.
The stock hit an intraday high of Rs. 270.00 and intraday low of 258.00. The net turnover during the day was Rs. 3584649.00.
